Bron:

| 23423 x gelezen

Determining central activation failure and peripheral fatigue in the course of sustained maximal voluntary contractions: a model-based approach

Maartje L. Schillings, Dick F. Stegeman, and Machiel J. Zwarts

Department of Clinical Neurophysiology, Radboud University Nijmegen Medical Centre, Nijmegen, and Interuniversity Institute for Fundamental and Clinical Human Movement Sciences, Nijmegen, Amsterdam, The Netherlands

Journal of Applied Physiology, 98: 2292-2297 (2005)

Promotie onderzoek: zie Agendapunten

Abstract:…

In the study of fatigue, several methods have been used to calculate the development of central activation failure (CAF) and peripheral fatigue (PF) in the course of a sustained maximal voluntary contraction (MVC). This paper presents a model that enables simultaneous determination of CAF and PF during sustained MVC by using only force registration and superimposed electrical stimulation. In the model, we explicitly use the assumption, which is virtually always made implicitly in earlier studies, that a constant relative fraction of maximal possible force is activated by the electrical stimulation. That fraction can be determined at the start and at the end of a sustained MVC. The model shows that in the course of a sustained MVC, CAF can be calculated by merely using 1) this fraction, 2) the amplitudes of the superimposed force responses to stimulation, and 3) the course of voluntary force. After CAF quantification, the development of PF during MVC becomes available as well. The present study first examines the model assumption with data of sustained MVCs of variable durations on six healthy subjects. Subsequently, it shows CAF values in a group of 27 healthy subjects determined with both the model and a method of linear interpolation for PF estimation. Model-based CAF values were significantly higher during, but not at the start and at the end of, a 2-min sustained MVC. Next to a well-justified CAF determination, the model has the advantage of simultaneously quantifying PF, which was not possible with the previous methods.

Volledige publicatie in pdf-formaat: klik hier

Geef een reactie

Zijbalk

Volg ons
Geen Evenementen
Recente Links
ma
di
wo
do
vr
za
zo
m
d
w
d
v
z
z
1
2
3
4
5
6
7
9
10
11
13
14
15
16
17
18
19
20
21
22
23
24
27
28
29
30
1
2
3
4
5
8th International Conference on HHV-6&7
08/04/2013 - 10/04/2013    
Hele dag
The HHV-6 Foundation is pleased to announce the 8th International Conference on HHV-6 & 7 being held April 8-10, 2013 in Paris, France.   The [...]
Wetenschap voor Patiënten: afl. 17. ME en de hersenen (Prof. De Meirleir)
12/04/2013    
09:00
Vrijdag 12 april is vanaf 9 uur de zeventiende uitzending met Kenny de Meirleir te bekijken. Het thema van deze uitzending is: ME en de [...]
FDA's Spring Stakeholders meeting for drug development for ME/CFS
25/04/2013    
12:00
The public workshop will be held on the afternoon of April 25 and all day, April 26, at the Bethesda Marriott, 5151 Pooks Hill Road, [...]
FDA's Spring Stakeholders meeting for drug development for ME/CFS
26/04/2013    
09:00
The public workshop will be held on the afternoon of April 25 and all day, April 26, at the Bethesda Marriott, 5151 Pooks Hill Road, [...]
Wetenschap voor Patiënten: afl. 18. Th1 en Th2 (Prof. De Meirleir)
26/04/2013    
09:00
Vrijdag 26 april is vanaf 9 uur de achttiende uitzending met Kenny de Meirleir te bekijken. Het thema van deze uitzending is: Th1 en Th2behandelde [...]
Evenement op 08/04/2013